Interestingly, the addition of an mTOR inhibitor to BH3 mimetics reduces the expression of the antiapoptotic protein Mcl-1 and allows high BIM levels to “prime” tumour cells for apoptosis23. This evidence concerns the gene BCL2L11 and neoplasm.